Sarah Ketterer - Causeway Capital Management
Holding/activity history for AstraZeneca PLC (AZN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 7,421,749 | 17.66 | Add 1,368.35% | 16.46 | $193.78 | $1,438,217,252 | SEC |
| 2025 Q4 | 505,449 | 1.28 | Reduce 5.29% | 0.06 | $183.86 | $92,931,891 | SEC |
| 2025 Q3 | 533,685 | 1.08 | Add 11.95% | 0.12 | $153.44 | $81,888,708 | SEC |
| 2025 Q2 | 476,724 | 1.05 | Add 11.14% | 0.11 | $139.76 | $66,626,954 | SEC |
| 2025 Q1 | 428,943 | 1.32 | Add 3.13% | 0.04 | $147.00 | $63,054,666 | SEC |
| 2024 Q4 | 415,935 | 1.24 | Add 69.62% | 0.51 | $131.04 | $54,504,114 | SEC |
| 2024 Q3 | 245,219 | 0.94 | Add 8.84% | 0.08 | $155.82 | $38,210,109 | SEC |
| 2024 Q2 | 225,294 | 0.96 | Reduce 9.24% | 0.08 | $155.98 | $35,141,382 | SEC |
| 2024 Q1 | 248,238 | 0.88 | Add 7.76% | 0.06 | $135.50 | $33,636,232 | SEC |
| 2023 Q4 | 230,361 | 0.79 | Add 29.70% | 0.18 | $134.70 | $31,029,651 | SEC |
| 2023 Q3 | 177,610 | 0.63 | Add 34.38% | 0.16 | $135.44 | $24,055,563 | SEC |
| 2023 Q2 | 132,173 | 0.50 | Reduce 18.34% | 0.10 | $143.14 | $18,919,228 | SEC |
| 2023 Q1 | 161,851 | 0.54 | Add 12.16% | 0.06 | $138.82 | $22,468,229 | SEC |
| 2022 Q4 | 144,310 | 0.57 | Reduce 5.25% | 0.02 | $135.60 | $19,568,418 | SEC |
| 2022 Q3 | 152,306 | 0.47 | Reduce 8.77% | 0.05 | $109.68 | $16,705,000 | SEC |
| 2022 Q2 | 166,948 | 0.55 | Reduce 18.19% | 0.12 | $132.14 | $22,061,000 | SEC |
| 2022 Q1 | 204,077 | 0.65 | Add 23.51% | 0.12 | $132.68 | $27,077,000 | SEC |
| 2021 Q4 | 165,236 | 0.42 | Reduce 4.77% | 0.02 | $116.50 | $19,250,000 | SEC |
| 2021 Q3 | 173,505 | 0.47 | Add 104.39% | 0.24 | $120.12 | $20,841,000 | SEC |
| 2021 Q2 | 84,891 | 0.21 | Buy | 0.21 | $119.80 | $10,170,000 | SEC |